BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 35794979)

  • 1. Downregulation of LRRC19 Is Associated with Poor Prognosis in Colorectal Cancer.
    Wang YJ; Liu M; Jiang HY; Yu YW
    J Oncol; 2022; 2022():5848823. PubMed ID: 35794979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulated Solute Carrier Family 4 Member 4 Predicts Poor Progression in Colorectal Cancer.
    Yang H; Lu Y; Lan W; Huang B; Lin J
    J Cancer; 2020; 11(12):3675-3684. PubMed ID: 32284764
    [No Abstract]   [Full Text] [Related]  

  • 3. Identification of the circRNA-miRNA-mRNA regulatory network and its prognostic effect in colorectal cancer.
    Yin TF; Zhao DY; Zhou YC; Wang QQ; Yao SK
    World J Clin Cases; 2021 Jun; 9(18):4520-4541. PubMed ID: 34222420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MTUS1 is a promising diagnostic and prognostic biomarker for colorectal cancer.
    Cheng LY; Huang MS; Zhong HG; Ru HM; Mo SS; Wei CY; Su ZJ; Mo XW; Yan LH; Tang WZ
    World J Surg Oncol; 2022 Aug; 20(1):257. PubMed ID: 35962436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of four novel prognosis biomarkers and potential therapeutic drugs for human colorectal cancer by bioinformatics analysis.
    Sun Z; Liu C; Cheng SY
    J Biomed Res; 2020 Oct; 35(1):21-35. PubMed ID: 33361643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global transcriptomic analysis identifies
    Xu B; Bai Z; Yin J; Zhang Z
    PeerJ; 2019; 7():e7091. PubMed ID: 31218131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The identification of a common different gene expression signature in patients with colorectal cancer.
    Zhao ZW; Fan XX; Yang LL; Song JJ; Fang SJ; Tu JF; Chen MJ; Zheng LY; Wu FZ; Zhang DK; Ying XH; Ji JS
    Math Biosci Eng; 2019 Apr; 16(4):2942-2958. PubMed ID: 31137244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SCARA5 is a Novel Biomarker in Colorectal Cancer by Comprehensive Analysis.
    Liu J; Zeng ML; Shi PC; Cao YP; Zhang JL; Xie YP
    Clin Lab; 2020 Jul; 66(7):. PubMed ID: 32658413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [BUB1 gene is highly expressed in gastric cancer:analysis based on Oncomine database and bioinformatics].
    Li X; He J; Yu M; Zhang W; Sun J
    Nan Fang Yi Ke Da Xue Xue Bao; 2020 May; 40(5):683-692. PubMed ID: 32897212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Potential Core Genes Associated With the Progression of Stomach Adenocarcinoma Using Bioinformatic Analysis.
    Yang B; Zhang M; Luo T
    Front Genet; 2020; 11():517362. PubMed ID: 33193601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SEMA6B Overexpression Predicts Poor Prognosis and Correlates With the Tumor Immunosuppressive Microenvironment in Colorectal Cancer.
    Li T; Yan Z; Wang W; Zhang R; Gan W; Lv S; Zeng Z; Hou Y; Yang M
    Front Mol Biosci; 2021; 8():687319. PubMed ID: 34938771
    [No Abstract]   [Full Text] [Related]  

  • 12. Identification and validation of key genes with prognostic value in non-small-cell lung cancer via integrated bioinformatics analysis.
    Wang L; Qu J; Liang Y; Zhao D; Rehman FU; Qin K; Zhang X
    Thorac Cancer; 2020 Apr; 11(4):851-866. PubMed ID: 32059076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the Expression of
    Chen C; Chen S; Pang L; Yan H; Luo M; Zhao Q; Lai J; Li H
    Biomed Res Int; 2020; 2020():6412593. PubMed ID: 32104702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of potential biomarkers with colorectal cancer based on bioinformatics analysis and machine learning.
    Hammad A; Elshaer M; Tang X
    Math Biosci Eng; 2021 Oct; 18(6):8997-9015. PubMed ID: 34814332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of candidate biomarkers and therapeutic drugs of colorectal cancer by integrated bioinformatics analysis.
    Zheng Z; Xie J; Xiong L; Gao M; Qin L; Dai C; Liang Z; Wang Y; Xue J; Wang Q; Wang W; Li X
    Med Oncol; 2020 Oct; 37(11):104. PubMed ID: 33078282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of key biomarkers associated with development and prognosis in patients with ovarian carcinoma: evidence from bioinformatic analysis.
    Shen J; Yu S; Sun X; Yin M; Fei J; Zhou J
    J Ovarian Res; 2019 Nov; 12(1):110. PubMed ID: 31729978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of genes and pathways leading to poor prognosis of non-small cell lung cancer using integrated bioinformatics analysis.
    Cui S; Lou S; Feng J; Tang X; Xiao X; Huang R; Guo W; Zhou Y; Huang F
    Transl Cancer Res; 2022 Apr; 11(4):710-724. PubMed ID: 35571642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Collagen family genes and related genes might be associated with prognosis of patients with gastric cancer: an integrated bioinformatics analysis and experimental validation.
    Weng K; Huang Y; Deng H; Wang R; Luo S; Wu H; Chen J; Long M; Hao W
    Transl Cancer Res; 2020 Oct; 9(10):6246-6262. PubMed ID: 35117235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Novel Biomarkers Associated With the Prognosis and Potential Pathogenesis of Breast Cancer via Integrated Bioinformatics Analysis.
    Wu M; Li Q; Wang H
    Technol Cancer Res Treat; 2021; 20():1533033821992081. PubMed ID: 33550915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential analysis revealing APOC1 to be a diagnostic and prognostic marker for liver metastases of colorectal cancer.
    Shen HY; Wei FZ; Liu Q
    World J Clin Cases; 2021 Jun; 9(16):3880-3894. PubMed ID: 34141744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.